01
Supply Chain or Distribution Failure
Supply chain risk is broadening and becoming more complex, extending well beyond keeping shipping vessels moving or suppliers’ manufacturing facilities intact.
From early-stage biotechnology start-ups to large multinational pharmaceuticals, the life sciences industry relies on innovation to meet shifting demands in health and improve treatment outcomes around the globe. However, emerging and established risks force organizations to operate in a volatile environment. While navigating research and development challenges, supply chain impacts and barriers to commercial sales, businesses also find themselves swept up in the fight for talent.
Finding new ways to cost-effectively manage risk and attract and retain a digitally-savvy workforce will accelerate innovation to create greater efficiencies, develop personalized medical treatments and access new markets. But with ever-evolving regulation, governance and production interruptions impacting the pace of progress, businesses across this sector must be resilient, investing in end-to-end solutions for their risk and human capital, as well as workforce health and wellbeing to protect vital talent.
According to our latest Global Risk Management Survey, the biggest risks facing the Life Sciences industry include:
01
Supply Chain or Distribution Failure
Supply chain risk is broadening and becoming more complex, extending well beyond keeping shipping vessels moving or suppliers’ manufacturing facilities intact.
02
Cyber Attack or Data Breach
Cyber attacks are, and will remain, a top risk across all geographies and industry sectors. All leaders need a cyber game plan.
03
Business Interruption
Previously, companies planned for isolated events. But the risk landscape is now more interconnected than ever before.
04
Regulatory or Legislative Changes
Uncertainty about upcoming regulatory changes affects business confidence, and companies active in multiple jurisdictions must track and comply with a wide variety of complex laws and regulations.
05
Failure to Attract or Retain Top Talent
Companies excel when they have the best possible talent in each role, from the C-suite to the front line. An inability to fill these slots and retain top-performing employees can have serious repercussions.
Report
From the global powerhouses of big pharma to the niche start-ups and technology giants venturing into the healthtech space, technology has transformed the opportunities and risks for life sciences businesses. Both innovation and digitalization have been fundamental for the research, production and distribution of medicine and medical devices.
Article
With the right level of preparedness, life sciences firms can take full advantage of the potential opportunities that 2025 will bring.
Article
Organisations recognize the growing value of technology and data assets relative to historical tangible assets, but they spend four times more budget on insurance for Property, Plant & Equipment risks
Read the ArticleArticle
How Cyber and Data Resilience Support Growth in Life Sciences
Read the ArticleArticle
While digitalization is delivering transformational change to R&D across the sector, it is also rapidly reshaping recruitment and retention strategies.
Read the ArticleReady to Explore Further?
Sign up to receive updates on the latest events,insights, news and more from our team.
You will soon receive an email to verify your email address. Please click on the link included in this note to complete the subscription process, which also includes providing consent in applicable locations and an opportunity to manage your email preferences.
Article
Article
Your request is being reviewed so we can align you to the best resources on our team. In the meantime, we invite you to explore some of our latest insights below.
Article
Article
If you encounter an issue, use the link below to start a new download.
Download Now